A BBS1 SVA F retrotransposon insertion is a frequent cause of Bardet-Biedl syndrome

被引:20
|
作者
Delvallee, Clarisse [1 ]
Nicaise, Samuel [1 ]
Antin, Manuela [2 ]
Leuvrey, Anne-Sophie [2 ]
Nourisson, Elsa [2 ]
Leitch, Carmen C. [3 ]
Kellaris, Georgios [3 ]
Stoetzel, Corinne [1 ]
Geoffroy, Veronique [1 ]
Scheidecker, Sophie [1 ,2 ]
Keren, Boris [4 ]
Depienne, Christel [4 ,5 ,6 ]
Klar, Joakim [7 ]
Dahl, Niklas [7 ]
Deleuze, Jean-Francois [8 ]
Genin, Emmanuelle [9 ]
Redon, Richard [10 ]
Demurger, Florence [11 ]
Devriendt, Koenraad [12 ,13 ]
Mathieu-Dramard, Michele [12 ,13 ,14 ]
Poitou-Bernert, Christine [15 ]
Odent, Sylvie [16 ,17 ]
Katsanis, Nicholas [3 ,18 ]
Mandel, Jean-Louis [2 ,19 ]
Davis, Erica E. [3 ,18 ]
Dollfus, Helene [20 ,21 ]
Muller, Jean [1 ,2 ]
机构
[1] Univ Strasbourg, Federat Med Translat Strasbourg FMT, Inst Genet Med Alsace IGMA, Lab Genet Med,INSERM,UMRS 1112,U1112, Strasbourg, France
[2] Hop Univ Strasbourg, Labs Diagnost Genet, Strasbourg, France
[3] Ann & Robert H Lurie Childrens Hosp Chicago, Stanley Manne Childrens Res Inst, Adv Ctr Translat & Genet Med ACTGeM, Chicago, IL 60611 USA
[4] Sorbonne Univ, Inst Cerveau & Moelle Epiniere ICM, Paris, France
[5] Hop La Pitie Salpetriere, AP HP, Dept Genet, Paris, France
[6] Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Essen, Germany
[7] Uppsala Univ, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden
[8] Ctr Natl Rech Genom Humaine CNRGH, Inst Biol Francois Jacob, Evry, France
[9] Univ Brest, CHRU Brest, INSERM, UMR1078, Brest, France
[10] Univ Nantes, CNRS, INSERM, Inst Thorax, Nantes, France
[11] Ctr Hosp Bretagne Atlantique, Serv Genet Med, Vannes, France
[12] Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium
[13] Katholieke Univ Leuven, Leuven, Belgium
[14] CHU Amiens, CLAD Nord France, Ctr Activite Genet Clin, Amiens, France
[15] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, INSERM,Nutr Dept,NutriOm Res Unit, Paris, France
[16] CHU Rennes, Serv Genet Clin, Ctr Reference Malad Rares CLAD Ouest, Rennes, France
[17] Univ Rennes, CNRS, IGDR Inst Genet & Dev Rennes, UMR 6290, Rennes, France
[18] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA
[19] Univ Strasbourg, CNRS, Inst Genet & Biol Mol & Cellulaire, INSERM,UMR 7104,U964,Dept Transl Med & Neurogenet, Illkirch Graffenstaden, France
[20] Hop Univ Strasbourg, Serv Genet Med, Strasbourg, France
[21] Hop Univ Strasbourg, CARGO, Ctr Reference Affect Rares Genet Ophtalmol, Filiere SENSGENE, Strasbourg, France
基金
美国国家卫生研究院;
关键词
Bardet‐ Biedl syndrome; BBS1; founder effect; Mobile element insertion; SVA F; DIAGNOSIS; ELEMENTS;
D O I
10.1111/cge.13878
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Bardet-Biedl syndrome (BBS) is a ciliopathy characterized by retinitis pigmentosa, obesity, polydactyly, cognitive impairment and renal failure. Pathogenic variants in 24 genes account for the molecular basis of >80% of cases. Toward saturated discovery of the mutational basis of the disorder, we carefully explored our cohorts and identified a hominid-specific SINE-R/VNTR/Alu type F (SVA-F) insertion in exon 13 of BBS1 in eight families. In six families, the repeat insertion was found in trans with c.1169 T > G, p.Met390Arg and in two families the insertion was found in addition to other recessive BBS loci. Whole genome sequencing, de novo assembly and SNP array analysis were performed to characterize the genomic event. This insertion is extremely rare in the general population (found in 8 alleles of 8 BBS cases but not in >10 800 control individuals from gnomAD-SV) and due to a founder effect. Its 2435 bp sequence contains hallmarks of LINE1 mediated retrotransposition. Functional studies with patient-derived cell lines confirmed that the BBS1 SVA-F is deleterious as evidenced by a significant depletion of both mRNA and protein levels. Such findings highlight the importance of dedicated bioinformatics pipelines to identify all types of variation.
引用
收藏
页码:318 / 324
页数:7
相关论文
共 50 条
  • [21] Identification of a novel Bardet-Biedl syndrome protein, BBS7, that shares structural features with BBS1 and BBS2
    Badano, JL
    Ansley, SJ
    Leitch, CC
    Lewis, RA
    Lupski, JR
    Katsanis, N
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (03) : 650 - 658
  • [22] A founder effect in the Newfoundland population reduces the Bardet-Biedl syndrome I (BBS1) interval to 1 cM
    Young, TL
    Woods, MO
    Parfrey, PS
    Green, JS
    Hefferton, D
    Davidson, WS
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (06) : 1680 - 1687
  • [23] Case Report: Identification Pathogenic Abnormal Splicing of BBS1 Causing Bardet-Biedl Syndrome Type I (BBS1) due to Missense Mutation
    Yan, Kai
    Sun, Yixi
    Yang, Yanmei
    Liu, Bei
    Dong, Minyue
    FRONTIERS IN GENETICS, 2022, 13
  • [24] Recurrence of a BBS1 variant in Bardet-Biedl patients from Prince Edward Island
    Alghaith, Fahad A.
    Mackay, Sara
    Wallace, Karin
    Locke, Jeff
    Robitaille, Johane M.
    Dyack, Sarah
    Arts, Heleen H.
    CLINICAL GENETICS, 2023, 104 (06) : 713 - 715
  • [25] A novel founder BBS1 mutation explains a unique high prevalence of Bardet-Biedl syndrome in the Faroe Islands
    Hjortshoj, T. Duelund
    Gronskov, K.
    Brondum-Nielsen, K.
    Rosenberg, T.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2009, 93 (03) : 409 - 413
  • [26] BBS1 Mutations in a Wide Spectrum of Phenotypes Ranging From Nonsyndromic Retinitis Pigmentosa to Bardet-Biedl Syndrome
    Estrada-Cuzcano, Alejandro
    Koenekoop, Robert K.
    Senechal, Audrey
    De Baere, Elfride B. W.
    de Ravel, Thomy
    Banfi, Sandro
    Kohl, Susanne
    Ayuso, Carmen
    Sharon, Dror
    Hoyng, Carel B.
    Hamel, Christian P.
    Leroy, Bart P.
    Ziviello, Carmela
    Lopez, Irma
    Bazinet, Alexandre
    Wissinger, Bernd
    Sliesoraityte, Ieva
    Avila-Fernandez, Almudena
    Littink, Karin W.
    Vingolo, Enzo M.
    Signorini, Sabrina
    Banin, Eyal
    Mizrahi-Meissonnier, Liliana
    Zrenner, Eberhard
    Kellner, Ulrich
    Collin, Rob W. J.
    den Hollander, Anneke I.
    Cremers, Frans P. M.
    Klevering, Jeroen
    ARCHIVES OF OPHTHALMOLOGY, 2012, 130 (11) : 1425 - 1432
  • [27] Gene Therapeutic Restoration of Peripheral Olfactory Impairment in BBS1 Knockout Mouse Model of Bardet-Biedl Syndrome
    Uytingco, Cedric R.
    Williams, Corey L.
    Green, Warren W.
    McIntyre, Jeremy C.
    Ukhanov, Kirill
    Zimmerman, Arthur D.
    Shively, Dana T.
    Zhang, Lian
    Nishimura, Darryl Y.
    Sheffield, Val C.
    Martens, Jeffery R.
    MOLECULAR THERAPY, 2017, 25 (05) : 314 - 315
  • [28] The Refractive Errors in Patients with Bardet-Biedl Syndrome (BBS)
    Yavuz Saricay, Leyla
    Moulton, Eric
    Gonzalez, Efren
    Fulton, Anne B.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [29] Genetic interaction of BBS1 mutations with alleles at other BBS loci can result in non-Mendelian Bardet-Biedl syndrome
    Beales, PL
    Badano, JL
    Ross, AJ
    Ansley, SJ
    Hoskins, BE
    Kirsten, B
    Mein, CA
    Froguel, P
    Scambler, PJ
    Lewis, RA
    Lupski, JR
    Katsanis, N
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) : 1187 - 1199
  • [30] Tolerability of Setmelanotide in Bardet-Biedl Syndrome (BBS) Patients
    Hillman, Leah
    Khorgami, Zhamak
    Allison, Lacey
    Chow, Geoffrey
    Lim, Robert
    Richards, Jesse
    OBESITY, 2023, 31 : 181 - 182